Skip to main content
MyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated July 2026

GLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide

GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.

Go to peptide profileCalculate your dose

Quickstart highlights

The GLOW blend combines BPC-157, TB-500, and GHK-Cu.

  • Three peptides: BPC-157 + TB-500 + GHK-Cu.
  • BPC-157: nitric oxide + VEGF angiogenesis for new capillary formation.
  • TB-500: actin-binding cell migration and wound closure.
  • GHK-Cu: collagen and elastin synthesis with matrix remodeling; a blue-green color is normal.
  • Evening injection can align with the overnight tissue-repair window.
  • Research-only: not FDA-approved; dosing is practitioner-reported, not from human trials.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-425012.5Once daily (evening)250 µg of each component — 12.5 units; starting dose; 5+5 mg vial provides ~20 doses
5-1250025Once daily500 µg each — 25 units; therapeutic aesthetic dose; standard GLOW blend maintenance

Your free GLOW Blend tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Create free account Already have one? Sign in

Reconstitution steps

  1. Reconstitute GLOW blend in 5 mL bacteriostatic water for approximately 2 mg/mL of each component.
  2. Swirl gently; GHK-Cu produces the characteristic blue-green color.
  3. Label with date; refrigerate at 2–8 °C. Use within 28 days.
  4. The blue-green color from GHK-Cu copper chelation is normal and indicates active peptide.

Supplies needed

12-week plan

  • 3 vials
  • 84 syringes
  • 15 mL bac water
  • 84 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Support tissue repair and skin and connective-tissue rejuvenation through the GLOW blend's angiogenic (BPC-157), cell-migration (TB-500), and collagen and matrix-remodeling (GHK-Cu) mechanisms, administered via daily subcutaneous injection.

Cycle length: 12 weeks on.

Off-cycle: 8 weeks off; assess skin and hair quality changes photographically before resuming.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted: refrigerate 2–8 °C; use within 28 days.

Injection & tracking tips

  • Inject subcutaneously; evening dosing can align with the overnight tissue-repair window.
  • Reconstitute with bacteriostatic water and refrigerate; the blue-green tint from GHK-Cu is expected and indicates active copper chelation.
  • GLOW blend composition and ratios vary by supplier — confirm the three active peptides and concentrations before dosing.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Standardized photographs at baseline, 4 weeks, and 12 weeks (same lighting, angle, camera).
  • Skin hydration measurement at baseline and 12 weeks if skin is the target.
  • Note injection-site tolerance and recovery or function changes weekly.
Log your cycle in the calculator →

How this works & references

The GLOW blend combines BPC-157, TB-500, and GHK-Cu. BPC-157 upregulates nitric oxide and VEGF-mediated angiogenesis, forming new capillaries that improve nutrient delivery to repairing tissue. TB-500 (a Thymosin Beta-4 fragment) binds G-actin to drive cell migration and wound closure. GHK-Cu stimulates collagen and elastin synthesis and matrix metalloproteinase-mediated remodeling, with antioxidant gene-expression effects. Together they target vascular supply, cellular repair machinery, and the structural matrix. None is FDA-approved, and the combination has no published human trials.

Sources

  • Source: Sikiric P et al. — BPC-157 cytoprotective and angiogenic effects. Curr Pharm Des. 2011. PMID: 21548867
  • Source: Goldstein AL, Hannappel E, Kleinman HK. — Thymosin beta4 and tissue repair. Trends Mol Med. 2005. PMID: 16099219
  • Source: Pickart L, Margolina A. — Regenerative actions of the GHK-Cu peptide. Int J Mol Sci. 2018. PMID: 29986520

Frequently asked questions

What is in the GLOW blend?
The GLOW blend combines three research peptides: BPC-157, TB-500 (a Thymosin Beta-4 fragment), and GHK-Cu (a copper peptide). Some compounding formulations vary, so confirm the exact peptides and concentrations with your supplier before dosing.
What is the difference between the GLOW and KLOW blends?
KLOW is the GLOW blend plus KPV, an alpha-MSH tripeptide added for extra NF-kB-driven anti-inflammatory activity. GLOW is the three-peptide version: BPC-157, TB-500, and GHK-Cu.
How long until the GLOW blend shows results?
Practitioner reports vary and no human trial data anchors expectations. Some users report skin-texture or recovery changes within 4–8 weeks of daily use, with collagen-related changes typically taking longer. Effects are not established in controlled trials.
Is the GLOW blend FDA approved?
No. BPC-157, TB-500, and GHK-Cu are research-only. BPC-157 was removed from the FDA 503A bulk drug substance list in 2023, and the combination has no legal commercial pathway in the US.
Can the GLOW blend be applied topically instead of injected?
GHK-Cu has topical clinical data for skin texture and firmness, and diluting the reconstituted blend for topical use is sometimes done. Injection provides more consistent systemic and dermal bioavailability. Confirm any approach with a licensed provider.

Related protocols

KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide

KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.

View protocol

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

View protocol

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

View protocol

Testagen Dosing Protocol: 20 mg Vial — Testicular Bioregulator & Testosterone Support Guide

Testagen (Lys-Glu-Asp-Gly tetrapeptide) Russian testicular bioregulator dosing guide — Leydig cell gene normalization for testosterone production optimization and male reproductive aging support.

View protocol

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Browse vetted clinicsView full peptide profile →